Healthpeak Properties, Inc. $DOC Stock Holdings Lowered by Equity Investment Corp

Equity Investment Corp reduced its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 2.3% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,487,967 shares of the real estate investment trust’s stock after selling 177,266 shares during the quarter. Healthpeak Properties makes up about 3.1% of Equity Investment Corp’s holdings, making the stock its 5th biggest holding. Equity Investment Corp’s holdings in Healthpeak Properties were worth $160,242,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Norges Bank bought a new stake in Healthpeak Properties in the 4th quarter worth $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Healthpeak Properties by 694.6% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after purchasing an additional 7,007,777 shares during the period. Bank of New York Mellon Corp raised its position in Healthpeak Properties by 60.3% during the 1st quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock valued at $253,949,000 after purchasing an additional 5,815,189 shares during the last quarter. Fuller & Thaler Asset Management Inc. lifted its holdings in Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after buying an additional 4,776,056 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its holdings in Healthpeak Properties by 214.0% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 4,230,551 shares of the real estate investment trust’s stock worth $98,050,000 after buying an additional 2,883,382 shares during the period. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on DOC shares. Barclays began coverage on Healthpeak Properties in a research note on Tuesday, July 7th. They set an “equal weight” rating and a $23.00 target price on the stock. Royal Bank Of Canada lifted their price target on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Scotiabank boosted their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 27th. Robert W. Baird upped their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a report on Thursday, August 13th. Finally, Cantor Fitzgerald raised their target price on shares of Healthpeak Properties from $20.00 to $23.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. Four research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $21.44.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock opened at $20.47 on Wednesday. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. The firm has a market capitalization of $14.12 billion, a P/E ratio of 58.49, a P/E/G ratio of 3.20 and a beta of 1.01. The business has a fifty day simple moving average of $21.35 and a two-hundred day simple moving average of $18.95. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $22.95.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. The firm had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The company’s revenue was up 11.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, equities analysts forecast that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be paid a $0.1017 dividend. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a dividend yield of 6.0%. Healthpeak Properties’s dividend payout ratio is presently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.